Biotech | October 11, 2021
Astra’s antibody injection trial indicates it can prevent and treat Covid-19
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
First and only therapy approved by the FDA for the treatment of pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis
Enoxaparin Sodium Injection, USP is used for prophylaxis of Deep Vein Thrombosis (DVT) in patients undergoing abdominal, hip or knee replacement surgery, and also for the treatment of acute DVT
The drug is indicated for mild and transient episodes of heart block
The group now has 320 approvals and has so far filed over 400 ANDAs
This marks Glenmark's first synthetic decapeptide injectable approval
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
Subscribe To Our Newsletter & Stay Updated
